Antituberculosis drugs in breastfeeding women
Treatments studied
Part of Infections clinical trials.
This trial studies how drugs for tuberculosis (TB) enter breast milk and affect the mother and baby. It helps find the right dose and safety for women who are breastfeeding, even if they do not have TB themselves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a breastfeeding woman aged 18 or older, between 3 and 24 months after giving birth to a healthy baby.
- You do not have tuberculosis (TB) infection or active TB disease.
- Your weight is between 25 and 100 kg (about 55 to 220 lbs).
- You are not taking any medicines for TB, diabetes, high blood pressure, HIV, heart disease, or other long-term conditions.
- Your breastfed baby has not been diagnosed with TB or is being treated for TB.
- You are not pregnant and do not have any acute illness at the time of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether higher or standard doses of the antibiotic rifampicin work better for treating pulmonary tuberculosis (a lung infection). You may benefit if you are starting TB treatment and have not had a bad reaction to rifampicin before.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
This study tests a daily combination of two medicines, rifapentine and isoniazid (called 1HP), to prevent tuberculosis (TB) in children under 13 years old. It includes children who have been exposed to TB or are at high risk, both those living with HIV and those without HIV.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
This study tests whether giving a personalized dose of rifampin (a key TB medicine) can improve treatment. It is for people with active TB that is sensitive to rifampin, and it involves frequent blood and urine tests to measure drug levels.
This study tests if bedaquiline can prevent tuberculosis (TB) in people who have been in close contact with someone with active TB, including people living with HIV. If you qualify, you would take the study medicine and be monitored to see if it prevents you from developing TB.
Hear when a new Tuberculosis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.